Year archive

Saniona — 2023 filings

All 30 regulatory filings released by Saniona (SANION) in 2023, sourced directly from the official regulator.

30 Filings

2023 Period

2023 filings (30)

Filing	Released	Lang
Saniona strengthens epilepsy pipeline with selection of SAN2355 as clinical candidate Regulatory Filings	2023-12-27	English
Saniona stärker sin epilepsipipeline med valet av SAN2355 som klinisk kandidat Regulatory Filings	2023-12-27	Swedish
Notice of Saniona AB extraordinary shareholders’ meeting Proxy Solicitation & Information Statement	2023-12-14	English
Kallelse till extra bolagsstämma i Saniona AB Proxy Solicitation & Information Statement	2023-12-14	Swedish
Saniona carries out a rights issue of units of approximately SEK 140 million Capital/Financing Update	2023-12-14	English
Saniona genomför en företrädesemission av units om cirka 140 MSEK Capital/Financing Update	2023-12-14	Swedish
Interim / Quarterly Report 2023 Interim / Quarterly Report 9M 2023	2023-11-30	Swedish
Interim / Quarterly Report 2023 Interim / Quarterly Report 9M 2023	2023-11-30	English
Saniona väljer Kv7 substans för att utse läkemedelskandidat inom epilepsi Regulatory Filings	2023-11-21	Swedish
Saniona promotes Kv7 epilepsy compound to candidate selection phase Regulatory Filings	2023-11-21	English
Interim / Quarterly Report 2023 Interim / Quarterly Report H1 2023	2023-08-31	English
Change in numbers of shares and votes in Saniona AB Share Issue/Capital Change	2023-08-31	English
Ändring av antalet aktier och röster i Saniona AB Share Issue/Capital Change	2023-08-31	Swedish
Saniona executes the set-off issue to Formue Nord Share Issue/Capital Change	2023-08-15	English
Saniona genomför kvittningsemissionen till Formue Nord Share Issue/Capital Change	2023-08-15	Swedish
Saniona reduces and extends loan Capital/Financing Update	2023-08-14	English
Saniona minskar och förlänger låneavtal Capital/Financing Update	2023-08-14	Swedish
Saniona enters into collaboration agreement with AstronauTx in Alzheimer’s disease Regulatory Filings	2023-07-17	English
Saniona ingår samarbetsavtal med AstronauTx kring Alzheimers sjukdom M&A Activity	2023-07-17	Swedish
Kommuniké från årsstämma den 25 maj 2023 i Saniona AB Declaration of Voting Results & Voting Rights Announcements	2023-05-25	Swedish
Bulletin from the Saniona AB annual shareholders’ meeting on May 25, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-05-25	English
Interim / Quarterly Report 2023 Interim / Quarterly Report Q1 2023	2023-05-25	Swedish
Interim / Quarterly Report 2023 Interim / Quarterly Report Q1 2023	2023-05-25	English
Annual Report (ESEF) 2022 Annual Report (ESEF) FY 2022	2023-04-28	Swedish
Notice of Saniona AB annual shareholders’ meeting Proxy Solicitation & Information Statement	2023-04-25	English
Kallelse till årsstämma i Saniona AB Proxy Solicitation & Information Statement	2023-04-25	Swedish
Saniona’s partner Medix receives favorable opinion for tesofensine for the treatment of obesity and weight management in Mexico Regulatory Filings	2023-02-25	English
Sanionas samarbetspartner Medix erhåller positivt yttrande om tesofensin för viktkontroll och behandling av fetma i Mexiko Regulatory Filings	2023-02-25	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report FY 2022	2023-02-23	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report FY 2022	2023-02-23	English